North American Contact Dermatitis Group patch test results for 2007-2008

Dermatitis

Volumn 24, Issue 1, 2013, Pages 10-21

  Fransway, Anthony F ^a   Zug, Kathryn A ^b   Belsito, Donald V ^b   DeLeo, Vincent A ^b   Fowler, Joseph F ^b   Maibach, Howard I ^b   Marks, James G ^b   Mathias, C G Toby ^b   Pratt, Melanie D ^b   Rietschel, Robert L ^b   Sasseville, Denis ^b   Storrs, Frances J ^b   Taylor, James S ^b   Warshaw, Erin M ^b   Dekoven, Joel ^b   Zirwas, Matthew ^b  

^a Dermatology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMO 2 BROMOMETHYLGLUTARONITRILE; 2 METHYL 4 ISOTHIAZOLIN 3 ONE; 2 PHENOXYETHANOL; 4 TERT BUTYLPHENOL; 5 CHLORO 2 METHYL 4 ISOTHIAZOLIN 3 ONE; ALLERGEN; BACITRACIN; BENZOCAINE; CINNAMALDEHYDE; COBALT CHLORIDE; COCAMIDOPROPYL BETAINE; DIAZOLIDINYL UREA; DICHROMATE POTASSIUM; DISULFIRAM; EPOXY RESIN; ETHYLENEDIAMINE; FORMALDEHYDE; FRAGRANCE; GLUTARALDEHYDE; HYDANTOIN; MERCAPTOBENZOTHIAZOLE; NEOMYCIN; NICKEL SULFATE; OXYBENZONE; PHENYLENEDIAMINE; POLYAMIDOAMINE; PROPOLIS; PROPYLENE GLYCOL; QUATERNIUM 15; TOLUENESULFONAMIDE DERIVATIVE;

ADULT; ARTICLE; CONTACT DERMATITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYROXYLON; OCCUPATIONAL SKIN DISEASE; PATCH TEST; PRIORITY JOURNAL;

EID: 84876278683     PISSN: 17103568     EISSN: 21625220     Source Type: Journal    
DOI: 10.1097/DER.0b013e318277ca50     Document Type: Article

References (61)

1. Rudner EJ. North American Group results. Contact Dermatitis 1977;3:208-209.
2. Storrs FJ, Rosenthal LE, Adams RM, et al. Prevalence and relevance of allergic reaction in patients patch tested in North America-1984 to 1985. J Am Acad Dermatol 1989;20(6):1038-1045.
3. Nethercott JR, Holness DL, Adams RM, et al. Patch testing with a routine screening tray in North America, 1985 through 1989: I. Frequency of response. Am J Contact Dermat 1991;2(2):122-129.
4. Marks JG, Belsito DV, De Leo VA, et al. North American Contact Dermatitis Group standard tray patch test results (1992 to 1994). Am J Contact Dermat 1995;6(3):160-165.
5. Marks JG, Belsito DV, De Leo VA, et al. North American Contact Dermatitis Group path test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol 1998;38(6):911-918.
6. Marks JG, Belsito DV, De Leo VA, et al. North American Contact Dermatitis Group patch-test results, 1996-1998. Arch Dermatol 2000;136:272-273.
7. Marks JG, Belsito DV, De Leo VA, et al. North American Contact Dermatitis Group patch-test results, 1998 to 2000. Am J Contact Dermat 2003;14(2):59-62.
8. Pratt MD, Belsito DV, De Leo VA, et al. NorthAmerican ContactDermatitis Group patch-test results, 2001-2002 study period. Dermatitis 2004;15(4):176-183
9. Erratum: Dermatitis 2005;16(2):106.
10. Warshaw EM, Belsito DV, De Leo VA, et al. North American Contact Dermatitis Group patch-test results, 2003-2004 study period. Dermatitis 2008;19(3):129-136.
11. Zug KA, Warshaw EM, Fowler JF Jr, et al. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermatitis 2009;20(3):149-160.
12. Rietchel RL, Mathias CGT, Taylor JS, et al. A preliminary report of the occupation of patients evaluated in patch test clinics. Am J Contact Dermatitis 2001;12:72-77.
13. Maouad M, Fleischer AB Jr, Sherertz BA. Significance-prevalence index number: a reinterpretation and enhancement of data from the North American Contact Dermatitis Group. J Am Acad Dermatol 1999;41:573-576.
14. Krob HA, Fleischer AB Jr, D'Agostino R Jr, et al. Prevalence and relevance of contact dermatitis allergens: a meta-analysis of 15 years of published data. J Am Acad Dermatol 2004;51:349-353.
15. Schnuch A, Geier J, Uter W, et al. National rates and regional differences in sensitization to allergens of the standard series. Population adjusted frequencies of sensitization (PAFS) in 40, 000 patients from a multicenter study (IVDK). Contact Dermatitis 1997;37:200-209.
16. Uter W. The 'overall yield' with the baseline series-a useful addition to the array of MOAHLFA factors describing departmental characteristics of patch tested patients. Contact Dermatitis 2011;65(6):322-328.
17. Rietschel RL, Fowler JF, Warshaw EM, et al. Detection of nickel sensitivity has increased in North American patch-tested patients. Dermatitis 2008;19(1):16-19.
18. Schram SE, Warshaw EM, Laumann A. Nickel hypersensitivity: a clinical review and call to action. Int J Dermatol 2010;49(2):115-125.
19. Lu LK, Warshaw EM, Dunnick CA. Prevention of nickel allergy: the case for regulation? Dermatol Clin 2009;27(2):155-161.
20. Warshaw EM, Buchholz HJ, Belsito DV, et al. Allergic patch test reactions associated with cosmetics: retrospective analysis of crosssectional data from the North American Contact Dermatitis Group, 2001-2004. J Am Acad Dermatol 2009;60(1):23-38.
21. Warshaw EM, Ratnayake DB, Maibach HI, et al. Positive patch-test reactions to iodopropynyl butylcarbamate: retrospective analysis of North American Contact Dermatitis Group data, from 1998 to 2008. Dermatitis 2010;21(6):303-310.
22. Walgrave SE, Warshaw EM, Glesne LA. Allergic contact dermatitis from propolis. Dermatitis 2005;16(4):209-215.
23. Carlsen BC, Andersen KE, Menne T, et al. Patients with multiple contact allergies: a review. Contact Dermatitis 2008;58:1-8.
24. Hoeck U, Lehmann S, Bjarnoe H, et al. New standardized allergens: the experimental TRUE Test Panel. Contact Dermatitis 2004;50(3):146.
25. Smack DP, Harrington AC, Dunn C, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs. bacitracin ointment. A randomized controlled trial. JAMA 1996;276:972-977.
26. Aakhus AE, Warshaw EM. Allergy to methyldibromoglutaronitrile/ phenoxyethanol (Euxyl k 400): regulatory issues, epidemiology, clinical characteristics, and management. Dermatitis 2011;22(3):127-140.
27. Scientific Committee on Consumer Products (SCCP) Opinion on Methyldibromoglutaronitrile (sensitization only) COLIPA N-P77. Adopted by the SCCP during the 8th plenary meeting of 20 June 2006. Available at: http://ec.europa.eu/health/ph-risk/committees/04-sccp/docs/sccp-o-060.pdf. Accessed June 27, 2012.
28. Thyssen JP, Johansen JD, Menne T. Contact allergy epidemics and their controls. Contact Dermatitis 2007;56:185-195.
29. Fowler J Jr, Taylor J, Storrs F, et al. Gold allergy in North America. Am J Contact Dermat 2001;12(1):3-5.
30. Rajpara S, Wilkinson MS, King CM, et al. The importance of propolis in patch testing-a multicentre survey. Contact Dermatitis 2009;61(5):287-290.
31. Goon AT, Bruze M, Zimerson E, et al. Screening for acrylate/methacrylate allergy in the baseline series: our experience in Sweden and Singapore. Contact Dermatitis 2008;59(5):307-313.
32. Aalto-Korte K, Henriks-Eckerman M, Kuuliala O, et al. Occupational methacrylate and acrylate allergy Vcross-reactions and possible screening allergens. Contact Dermatitis 2010;63(6):301-312.
33. Warshaw EM, Botto NC, Maibach HI, et al. Positive patch-test reactions to propylene glycol: a retrospective cross-sectional analysis from the American Contact Dermatitis Group, 1996 to 2006. Dermatitis 2009;20(1):14-20.
34. Fowler JF Jr. Addition of nonspecific endogenous eczema to the nomenclature of dermatitis. Arch Dermatol 2008;144(2):249-250.
35. Li LF, Liu G, Wang J. Prognosis of unclassified eczema: a follow-up study. Arch Dermatol 2008;144(2):160-164.
36. Cheng LS, Alikhan A, Maibach HI. Compilation of international standards for patch testing methodology and allergens. Dermatitis 2009;20(5):257-260.
37. Andersen KE, Flemming A. The reaction index and positivity ratio revisited. Contact Dermatitis 2008;58(1):28-31.
38. Thyssen JP, Linneberg A, Menne T. The epidemiology of contact allergy in the general population-prevalence and main findings. Contact Dermatitis 2007;57:287-299.
39. Mirshahpanah P, Maibach HI. Relationship of patch test positivity in a general versus an eczema population. Contact Dermatitis 2007;56:125-130.
40. Kuss O, Stang A. The P-value-a well-understood and properly used statistical concept? Contact Dermatitis 2012:66: 1-3.
41. Warshaw EM, Furda L, Maibach HI, et al. Anogenital dermatitis in patients referred for patch testing: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004. Arch Dermatol 2008;144(6):749-755.
42. Zug KA, Kornik R, Belsito DV, et al. Patch-testing North American lip dermatitis patients: data from the North American Contact Dermatitis Group2001-2004. Dermatitis 2008;19(4):202-208.
43. Rietschel RL, Warshaw EM, Sasseville D, et al. Common contact allergens associated with eyelid dermatitis: data from the North American Contact Dermatitis Group 2003-2004 study period. Dermatitis 2007;18(2):78-81.
44. Warshaw EM, Ahmed RL, Belsito DV, et al. Contact dermatitis of the hands: cross-sectional analyses of North American Contact Dermatitis Group Data, 1994-2004. J Am Acad Dermatol 2007;57(2):201-214.
45. Zug KA, Rietschel RL, Warshaw EM, et al. The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001-2004. J Am Acad Dermatol 2008;59(3):426-431.
46. Warshaw EM, Schram SE, Maibach HI, et al. Occupationally-related contact dermatitis in North American health care workers referred for patch testing: a retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group 1998-2004. Dermatitis 2008;19(5):261-274.
47. Warshaw EM, Schram SE, Belsito DV, et al. Shoe Allergens: Review of the Literature and Retrospective Analysis of Cross-sectional Data from the North American Contact Dermatitis Group 2001-2004. Dermatitis 2007:18(4):191-202.
48. Warshaw EM, Schram SE, Rietschel RL, et al. Patch test reactions to topical anesthetics: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group 2001-2004 Dermatitis 2008;19(2):81-85.
49. Warshaw EM, Botto, NC, Zug KA, et al. Contact dermatitis associated with food: retrospective cross-sectional analysis from the North American Contact Dermatitis Group, 2001-2004. Dermatitis 2008;19(5):252-260.
50. Warshaw EM, Buchholz HJ, Belsito DV, et al. Allergic patch test reactions associated with cosmetics. J Am Acad Dermatol 2009;60(1):23-38.
51. Warshaw EM, Raju SI, Fowler JF Jr, et al. Positive patch test reactions in older individuals: retrospective analysis from the North American Contact Dermatitis Group, 1994-2008. J Am Acad Dermatol 2012;66(2):229-240.
52. Zug KA, McGinley-Smith D, Warshaw EM, et al. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004. Arch Dermatol 2008;144(10):1329-1336.
53. Akyol A, Boyvat A, Peksari Y, et al. Contact sensitivity to standard series allergens in 1038 patients with contact dermatitis in Turkey. Contact Dermatitis 2005;52(6):333-337.
54. Uter W, Ramsch C, Aberer W, et al. The European baseline series in 10 European countries, 2005/2006Vresults of the European Surveillance System on Contact Allergies (ESSCA). Contact Dermatitis 2009;61:31-38.
55. Lazarov A. European standard series patch test results from a contact dermatitis clinic in Israel during the 7-year period from 1998 to 2004. Contact Dermatitis 2006;55(2):73-76.
56. De Groot AC, Maibach HI. Frequency of sensitization to common allergens: comparison between Europe and the USA. Contact Dermatitis 2010;62(6):325-329.
57. Bruynzeel DP, Dipgen TL, Andersen KE, et al. Monitoring the European standard series in 10 centres 1996-2000. Contact Dermatitis 2005;53(3):146-149.
58. Landeck L, Schalock PC, Baden LA, et al. Patch-testing with the standard series at the Massachusetts General Hospital, 1998 to 2006. Dermatitis 2009;20(2):89-94.
59. Nguyen SH, Dang TP, MacPherson C, et al. Prevalence of patch test results from 1970 to 2002 in a multi-centre population in North America (NACDG). Contact Dermatitis 2008;58(2):101-106.
60. Freireich-Astman M, David M, Trattner A. Standard patch test results in patients with contact dermatitis in Israel: age and sex differences. Contact Dermatitis 2007:56(2):103-107.
61. Uter W, Hegewald J, Aberer W. The European standard series in 9 European countries, 2002/2003Vfirst results of the European Surveillance System on Contact Allergies. Contact Dermatitis 2005;53(3):136-145.